TORRENT PHARMA LTD, RETESTING AFTER BREAKOUTTORRENT PHARMA LTD, Retesting after trendline breakout. keep eyes on it. looking good for long.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
56.45 INR
19.11 B INR
113.58 B INR
105.79 M
About TORRENT PHARMACEUTICALS L
Sector
Industry
Website
Headquarters
Ahmedabad
Founded
1959
ISIN
INE685A01028
FIGI
BBG000D80W88
Torrent Pharmaceuticals Ltd. engages in the research, development, manufacture, and marketing of generic pharmaceutical formulations. It offers pharmaceutical products to local and international markets, particularly in countries such as India, USA, Germany, Brazil, and other countries. The company was founded by Uttambhai Nathalal Mehta in 1959 and is headquartered in Ahmedabad, India.
Related stocks
TORRENT PHARMACEUTICALS LTD. (TORPHARM) View: Bullish on confirmed breakout.
Bias: Positive momentum building.
Strategy:
BUY: Above ₹3600 (on weekly closing basis with strong volume confirmation).
Targets (T):
T1: ₹3750
T2: ₹3950+
Stop-Loss (SL): ₹3400 (on weekly closing basis).
Reasoning:
Strong support at ₹3000-₹3050.
Challengin
TORNTPHARM : Bullish SetupBullish breakout from Bigger Channel pattern as well as a smaller channel pattern. Expecting 10% from the breakout level.
Reason For Bullish Setup
1) Breakout from large channel pattern
2) Breakout from smaller channel pattern
3) Breakout from inverted head and shoulder inside smaller channel p
Symmetrical Triangle pattern in Torrent Pharma Symmetrical Triangle Breakout Setup
Torrent Pharmaceuticals Ltd (TORNTPHARM)
Breakout Level: ₹3,300
Stop Loss: ₹3,150 (below triangle support)
Target: ₹4,000 (based on height of triangle)
Risk:Reward: ~2.8:1
✅ Technical Confirmation:
RSI near 52 — momentum shifting bullish above 55.
MACD positiv
Torrent Pharma to touch 3100 again ?Torrent Pharma is in corrective phase for a while. This correction is not going to end anytime soon, however we still have opportunity to make some money here.
Currently on the Daily chart its in complex correction in which we have already completed Wave W, what's left is Wave X and Wave Y. Once w
Torrent Pharma: Channel range targets.On the daily chart, Torrent Pharma is forming a channel, which has given a rejection on the upper channel line. Now the immediate support range is between 3093.70 and 3074, where a short side entry is possible on breakdown for the target of the lower channel line.
Inside the bigger picture, below t
TORNTPHARM Final Bearish move before bulls entry????Yesssss!!!! Chart patterns suggest me the above titled opinion...
TORNTPHARM has been travelling in a Ascending Expanding channel pattern IN A BULLISH MODE MAKING SERIES OF HIGHER HIGHS AND HIGHER LOWS... (shown below)
Inside the bullish pattern , it is now currently in the downward phase that to
TORNTPHARM 1. HH formation
2. Weak buyers were removed at every up move
3. After R, SL can be reduced
4. Strict SL
## TORNTPHARM Price AnalysisTorrent Pharmaceuticals (TORNTPHARM) is currently trading near ₹3,254, maintaining a strong uptrend over the past several years. The stock has delivered a return of approximately 165% from July 2020 to November 2024, including a stock split, highlighting its consistent long-term growth.
**Valuation
Looks like a good long opportunityThe stock has potentially broken above the short-term descending trendline, signaling a bullish reversal. Current support is near ₹3,180, with resistance at ₹3,320 (recent high). A sustained move above ₹3,320 could target ₹3,450 or higher if momentum continues.
Entry: Enter a long position if the p
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TORNTPHARM is 3,439.55 INR — it has increased by 0.63% in the past 24 hours. Watch TORRENT PHARMACEUTICALS LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange TORRENT PHARMACEUTICALS LTD. stocks are traded under the ticker TORNTPHARM.
TORNTPHARM stock has risen by 2.94% compared to the previous week, the month change is a 6.98% rise, over the last year TORRENT PHARMACEUTICALS LTD. has showed a 17.75% increase.
We've gathered analysts' opinions on TORRENT PHARMACEUTICALS LTD. future price: according to them, TORNTPHARM price has a max estimate of 4,160.00 INR and a min estimate of 3,185.00 INR. Watch TORNTPHARM chart and read a more detailed TORRENT PHARMACEUTICALS LTD. stock forecast: see what analysts think of TORRENT PHARMACEUTICALS LTD. and suggest that you do with its stocks.
TORNTPHARM reached its all-time high on Oct 10, 2024 with the price of 3,589.95 INR, and its all-time low was 56.10 INR and was reached on Oct 27, 2008. View more price dynamics on TORNTPHARM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TORNTPHARM stock is 2.30% volatile and has beta coefficient of 0.65. Track TORRENT PHARMACEUTICALS LTD. stock price on the chart and check out the list of the most volatile stocks — is TORRENT PHARMACEUTICALS LTD. there?
Today TORRENT PHARMACEUTICALS LTD. has the market capitalization of 1.15 T, it has decreased by −0.75% over the last week.
Yes, you can track TORRENT PHARMACEUTICALS LTD. financials in yearly and quarterly reports right on TradingView.
TORRENT PHARMACEUTICALS LTD. is going to release the next earnings report on Jul 29, 2025. Keep track of upcoming events with our Earnings Calendar.
TORNTPHARM earnings for the last quarter are 15.40 INR per share, whereas the estimation was 14.35 INR resulting in a 7.33% surprise. The estimated earnings for the next quarter are 17.19 INR per share. See more details about TORRENT PHARMACEUTICALS LTD. earnings.
TORRENT PHARMACEUTICALS LTD. revenue for the last quarter amounts to 29.59 B INR, despite the estimated figure of 29.91 B INR. In the next quarter, revenue is expected to reach 31.51 B INR.
TORNTPHARM net income for the last quarter is 4.98 B INR, while the quarter before that showed 5.03 B INR of net income which accounts for −0.99% change. Track more TORRENT PHARMACEUTICALS LTD. financial stats to get the full picture.
TORRENT PHARMACEUTICALS LTD. dividend yield was 0.99% in 2024, and payout ratio reached 56.67%. The year before the numbers were 1.08% and 57.21% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 15, 2025, the company has 20.01 K employees. See our rating of the largest employees — is TORRENT PHARMACEUTICALS LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TORRENT PHARMACEUTICALS LTD. EBITDA is 37.21 B INR, and current EBITDA margin is 32.09%. See more stats in TORRENT PHARMACEUTICALS LTD. financial statements.
Like other stocks, TORNTPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TORRENT PHARMACEUTICALS LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TORRENT PHARMACEUTICALS LTD. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TORRENT PHARMACEUTICALS LTD. stock shows the buy signal. See more of TORRENT PHARMACEUTICALS LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.